Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

MorphoSys Announces its Licensee Janssen has Initiated a Phase 23 Program GALAXI to Evaluate TremfyaR Guselkumab in Crohn's Disease news with additional features

$
0
0
DGAPNews MorphoSys AG Key words StudyMiscellaneous10.07.2018 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany July 10 2018MorphoSys Announces its Licensee Janssen has Initiated a Phase 23 Program GALAXI to ...

Viewing all articles
Browse latest Browse all 2985

Trending Articles